305 COLLEGE ROAD EAST, PRINCETON, NJ
CytoSorbents Corporation Announces 1-for-20 Reverse Stock Split
Q2 2026 Earnings Conference Call August 6, 2026
Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update
Annual Report to Security Holders
Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update.
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Reports Third Quarter 2025 Financial Results and Provides Business Update
Q2
Q1
Amended Annual Report
FY 2025
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
Free Writing Prospectus
Correspondence